Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies
Paediatric gliomas categorised as low- or high-grade vary markedly from their adult counterparts, and denoted as the second most prevalent childhood cancers after leukaemia. As compared to adult gliomas, the studies of diagnostic and prognostic biomarkers, as well as the development of therapy in pa...
Main Authors: | Jean Yin Tan, Ipalawattage Vindya Stephnie Wijesinghe, Muhamad Noor Alfarizal Kamarudin, Ishwar Parhar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/607 |
Similar Items
-
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
by: Rui-Chao Chai, et al.
Published: (2020-03-01) -
BRAF non-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF V600E but without a survival advantage
by: Wei Wang, et al.
Published: (2021-05-01) -
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
by: Karisa C. Schreck, et al.
Published: (2019-08-01) -
Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials
by: Sudarshawn Damodharan, et al.
Published: (2022-05-01) -
K27M-mutant histone-3 as a novel target for glioma immunotherapy
by: Katharina Ochs, et al.
Published: (2017-07-01)